LifeScan

Khosla leads $12M series B for digital health player Hello Heart

Hello Heart, the maker of a digital health tool for people with hypertension, reeled in a $12 million series B to build its sales and engineering teams.

Amirah Al Idrus Aug 2, 2019 8:15am

Johnson & Johnson receives $2.1B bid for LifeScan diabetes unit

Mar 16, 2018 9:54am

Chinese buyers mull bids for J& J’s $4B diabetes unit: report

Jan 18, 2018 9:27am

JJ blood glucose monitor and welldoc app

FDA clears integration of J&J, Welldoc tech for real-time diabetes management

Dec 14, 2016 11:03am